Prevalence of plasmodium falciparum and non-falciparum infections by photo-induced electron transfer-PCR in a longitudinal cohort of individuals enrolled in a mass drug administration trial in Southern Province, Zambia

American Journal of Tropical Medicine and Hygiene

Volumn 103, Issue 2, 2020, Pages 82-89

  Chishimba, Sandra ^a   Mwenda, Mulenga ^a   Mambwe, Brenda ^a   Mulube, Conceptor ^a   Chalwe, Victor ^b   Moonga, Hawela ^c   Hamainza, Busiku ^c   Chizema Kawesha, Elizabeth ^c   Steketee, Richard W ^d   Domingo, Gonzalo ^d   Fraser, Maya ^d   Kahn, Maria ^d   Pal, Sampa ^d   Silumbe, Kafula ^a   Conner, Ruben O ^d   Bennett, Adam ^e   Porter, Travis R ^f   Eisele, Thomas P ^f   Miller, John M ^a   Bridges, Daniel J ^a  

^a Malaria Control and Evaluation Partnership in Africa (MACEPA)   (Zambia)

^b Zambia Ministry of Health Provincial Medical Office   (Zambia)

^c MINISTRY OF HEALTH   (Zambia)

^d PATH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; RNA 18S; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; PIPERAQUINE; QUINOLINE DERIVATIVE;

ANTIGEN BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; DISEASE TRANSMISSION; FALSE NEGATIVE RESULT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MASS DRUG ADMINISTRATION; MIXED INFECTION; PHOTO INDUCED ELECTRON TRANSFER POLYMERASE CHAIN REACTION; PLASMODIUM OVALE MALARIA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREVALENCE; SENSITIVITY AND SPECIFICITY; SPECIES IDENTIFICATION; ZAMBIA; COMBINATION DRUG THERAPY; CONTROLLED STUDY; GENETICS; MALARIA; PLASMODIUM FALCIPARUM; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION;

ANTIMALARIALS; ARTEMISININS; DRUG THERAPY, COMBINATION; HUMANS; LONGITUDINAL STUDIES; MALARIA; MALARIA, FALCIPARUM; MASS DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; PREVALENCE; QUINOLINES; REAL-TIME POLYMERASE CHAIN REACTION; ZAMBIA;

EID: 85089301663     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.19-0668     Document Type: Article

References (30)

1. Ministry of Health of the Republic of Zambia, 2017. National Malaria Elimination Strategic Plan 2017-2021. NMCC.
2. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J, 2013. Mass drug administration for malaria. Cochrane Database Syst Rev 12: CD008846.
3. Eisele TP et al., 2016. Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in Southern Province Zambia: a cluster-randomized controlled trial. J Infect Dis 214: 1831-1839.
4. Okell LC, Ghani AC, Lyons E, Drakeley CJ, 2009. Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. J Infect Dis 200: 1509-1517.
5. Lucchi NW et al., 2016. Evaluation of the illumigene malaria LAMP: a robust molecular diagnostic tool for malaria parasites. Sci Rep 6: 36808.
6. Hofmann N et al., 2015. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med 12: e1001788.
7. Okell LC et al., 2012. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun 3: 1237.
8. Lucchi NW et al., 2014. PET-PCR method for the molecular detection of malaria parasites in a national malaria surveillance study in Haiti, 2011. Malar Journal 13: 462.
9. Talundzic E, Maganga M, Masanja IM, Peterson DS, Udhayakumar V, Lucchi NW, 2014. Field evaluation of the photo-induced electron transfer fluorogenic primers (PET) real-time PCR for the detection of Plasmodium falciparum in Tanzania. Malar Journal 13: 31.
10. Eisele TP et al., 2015. Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial. Trials 16: 347.
11. Bennett A et al., 2020. A longitudinal cohort to monitor malaria infection incidence during mass drug administration in Southern Province, Zambia. Am J Trop Med Hyg 103 (Suppl 2): 54-65.
12. Lucchi NW, Narayanan J, Karell MA, Xayavong M, Kariuki S, DaSilva AJ, Hill V, Udhayakumar V, 2013. Molecular diagnosis of malaria by photo-induced electron transfer fluorogenic primers: pet-PCR. PLoS One 8: e56677.
13. Golassa L, Enweji N, Erko B, Aseffa A, Swedberg G, 2013. Detection of a substantial number of sub-microscopic Plasmodium falciparum infections by polymerase chain reaction: a potential threat to malaria control and diagnosis in Ethiopia. Malar J 12: 352.
14. Nguyen T-N et al., 2018. The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study. Lancet Infect Dis 18: 565-572.
15. Dalrymple U, Arambepola R, Gething PW, Cameron E, 2018. How long do rapid diagnostic tests remain positive after anti-malarial treatment? Malar Journal 17: 228.
16. Iqbal J, Sher A, Rab A, 2000. Plasmodium falciparum histidine-rich protein 2-based immunocapture diagnostic assay for malaria: cross-reactivity with rheumatoid factors. J Clin Microbiol 38: 1184-1186.
17. Luchavez J, Baker J, Alcantara S, Belizario V Jr., Cheng Q, McCarthy JS, Bell D, 2011. Laboratory demonstration of a prozone-like effect in HRP2-detecting malaria rapid diagnostic tests: implications for clinical management. Malar J 10: 286.
18. Laban NM et al., 2015. Comparison of a PfHRP2-based rapid diagnostic test and PCR for malaria in a low prevalence setting in rural southern Zambia: implications for elimination. Malar J 14: 25.
19. Gupta H et al., 2017. Molecular surveillance of pfhrp2 and pfhrp3 deletions in Plasmodium falciparum isolates from Mozambique. Malar J 16: 416.
20. Parr JB et al., 2017. Pfhrp2-deleted Plasmodium falciparum parasites in the Democratic Republic of the Congo: a national cross-sectional survey. J Infect Dis 216: 36-44.
21. Plucinski MM et al., 2019. Screening for pfhrp2/3-deleted Plasmodium falciparum, non-falciparum, and low-density malaria infectionsbyamultiplexantigenassay.JInfectDis219:437-447.
22. Thomson R et al., 2019. Pfhrp2 and pfhrp3 gene deletions that affect malaria rapid diagnostic tests for Plasmodium falciparum: analysis of archived blood samples from 3 African countries. J Infect Dis 220: 1444-1452.
23. Parr JB et al., 2016. Estimation of Plasmodium falciparum transmission intensity in Lilongwe, Malawi, by microscopy, rapid diagnostic testing, and nucleic acid detection. Am J Trop Med Hyg 95: 373-377.
24. Kobayashi T, Sikalima J, Parr JB, Chaponda M, Stevenson JC, Thuma PE, Mulenga M, Meshnick SR, Moss WJ, For The Southern And Central Africa International Centers Of Excellence For Malaria Research, 2019. The search for Plasmodium falciparum histidine-rich protein 2/3 deletions in Zambia and implications for Plasmodium falciparum histidine-rich protein 2-based rapid diagnostic tests. Am J Trop Med Hyg 100: 842-845.
25. Das S et al., 2017. Performance of a high-sensitivity rapid diagnostic test for Plasmodium falciparum malaria in asymptomatic individuals from Uganda and Myanmar and naive human challenge infections. Am J Trop Med Hyg 97: 1540-1550.
26. Imwong M, Hanchana S, Malleret B, Rénia L, Day NPJ, Dondorp A, Nosten F, Snounou G, White NJ, 2014. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol 52: 3303-3309.
27. Nambozi M, Malunga P, Mulenga M, Van Geertruyden J-P, D'Alessandro U, 2014. Defining the malaria burden in Nchelenge district, northern Zambia using the World Health Organization malaria indicators survey. Malar J 13: 220.
28. Wolfe HL, 1968. Plasmodium ovale in Zambia. Bull World Health Organ 39: 947-948.
29. Sitali L, Miller OM, Mwenda MC, Bridges DJ, Hawela MB, Hamainza B, Kawesha EC, Eisele TP, Chipeta J, Lindtjørn B, 2019. Distribution of Plasmodium species and assessment of performance of diagnostic tools used during a malaria survey in Southern and Western Provinces of Zambia. Malar J 18, 130.
30. Blossom DB, King CH, Armitage KB, 2005. Occult Plasmodium vivax infection diagnosed by a polymerase chain reaction-based detection system: a case report. Am J Trop Med Hyg 73: 188-190.